You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 64.4 KDa. Observed: 85-95 KDa, reducing conditions
Mouse
Gln20-Phe355
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.8 KDa. Observed: 60-70 KDa, reducing conditions
Human
Asp36-Lys257
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 46.5 KDa. Observed: 55-65 KDa, reducing conditions
Human
Ala22-His205
C-mFc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 49.1 KDa. Observed: 55-60 KDa, reducing conditions
Human
(SLLMWITQC)&Ile21-Met119&Gly25-Ile308 (Ala269Val)
C-10His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 47 KDa. Observed: 55-70 KDa, reducing conditions
Human
Ala22-His205
C-Fc
50 μg, 500 μg, 1 mg, 10 μgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.4 KDa. Observed: 45-60 KDa, reducing conditions
Human
Gln32-Leu360
C-6His-Avi
20 μg, 100 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 40.6 KDa. Observed: 45-50 KDa, reducing conditions
Human
Thr41-Asp171
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 81.2 KDa. Observed: 85-100 KDa, reducing conditions
Human
Ser27-Pro524
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37&38.3 KDa. Observed: 40-60 KDa, reducing conditions
Cynomolgus
Phe22-Ala105&Gln22-Asp117
C-Fc-Flag&C-Fc-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 58.5 KDa. Observed: 70-100 KDa, reducing conditions
Human
Asn22-Ile320
C-Fc
10 μg, 500 μg, 1 mg, 50 μg